Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Jiang, Er-Lie  [Clear All Filters]
2024
Xu Z-L, Xu L-P, Zhang Y-C, Zhou Y-H, Jiang E-L, Zhang J-P, Fu B, Ouyang G-F, Song X-M, Zhang X-J, et al. The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group. Haematologica. 2024.
2023
Xu C-H, Chen X, Zhu G-Q, Yi H-M, Chen S-L, Liu T, Yu Y-T, Zhang Q-H, Jiang E-L, Feng S-Z. Diagnostic performance and clinical impacts of metagenomic sequencing after allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2023.
Ma Y-Y, Wei Z-L, Xu Y-J, Shi J-M, Yi H, Lai Y-R, Jiang E-L, Bin Wang S-, Wu T, Gao L, et al. Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study. Cancer. 2023.
Liu S, Zhou Z, Zhai W-J, Song X-N, Li Q, Jiang E-L, Feng S-Z, Sun J-L. [The Relationship between Occurrence of aGVHD in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation and Immune Cell Components in Graft]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(2):539-545.
2022
Xu L-P, Lu D-P, Wu D-P, Jiang E-L, Liu D-H, Huang H, Sun Z-M, Li N-N, Liu Q-F, Zhang X, et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transplant Cell Ther. 2022.
2019
Cao Y-G, He Y, Zhang S-D, Liu Z-X, Zhai W-H, Ma Q-L, Pang A-M, Wei J-L, Yang D-L, Huang Y, et al. Conditioning regimen of 5-day decitabine administration for allogeneic stem cell transplantation in patients with myelodysplastic syndrome and myeloproliterative neoplasms. Biol Blood Marrow Transplant. 2019.
2013
Yan F-H, Wang M, Huang Y, Jiang E-L, Ma Q-L, Wei J-L, Pang A-M, Zhang R-L, Feng S-Z, Han M-Z. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(12):1020-3.